Professor Anne Brunet's lab at Stanford focuses on understanding the biological processes of aging and how the brain affects the aging of other organs. They use unique models like the African killifish to study aging due to its short lifespan and develop advanced tools like machine learning and spatial transcriptomics to analyze complex data. By investigating how the peripheral nervous system and immune cells influence the aging process, the lab aims to uncover potential therapies to enhance longevity and counter age-related diseases.

Dr. Jesse M. Engreitz's lab at Stanford University focuses on understanding how DNA regulatory sequences control gene expression, particularly in the context of diseases like Alagille Syndrome. Through innovative techniques like CRISPR and high-throughput screening, the lab aims to develop genetic tools that can correct gene expression patterns in human cells. This research not only seeks to provide insights into gene regulation but also aims to offer new therapeutic approaches for genetic disorders.

Dr. Jonathan K Pritchard's lab at Stanford University is focused on understanding the genetic basis of human diseases. The research aims to identify which genes and their variants contribute to various traits and diseases, ultimately leading to insights that could inform therapeutic targets. The lab utilizes advanced statistical models and machine learning techniques to analyze genetic data and improve predictions about gene effects on health.

Dr. Anshul Kundaje's lab at Stanford University focuses on understanding how genetic variations affect human health by studying the noncoding regions of the genome. The lab uses advanced machine learning techniques and innovative experimental methods to create detailed maps that show how genetic changes can influence cell behavior and contribute to diseases. Students in this lab will gain valuable experience in computational biology and functional genomics.

Dr. William James Greenleaf's lab at Stanford University focuses on understanding complex biological systems using cutting-edge single-cell technologies. The research aims to unravel gene regulatory dynamics, particularly in the developing human heart, which has significant implications for understanding congenital heart defects. By leveraging advanced computational tools and multi-omic data analysis, the team is developing models that predict how genetic variations impact gene expression and cellular behavior during development.

The lab focuses on understanding how RNA editing impacts the immune system, specifically in regulating the body's response to infections while avoiding attacks on its own cells. By studying an enzyme called ADAR1, the lab aims to uncover how this enzyme edits RNA to prevent autoimmune diseases and enhance our understanding of related inflammatory conditions. This work combines genetic screening and biochemical methods to identify how specific RNA molecules are processed within cells, paving the way for new therapeutic approaches.

Dr. Polly Morrell Fordyce's lab focuses on developing innovative microfluidic technologies to enhance personalized anti-cancer immunotherapies. By studying the interactions between T cell receptors and antigen-presenting molecules, the lab aims to identify which combinations can effectively activate T cells to combat cancer cells. This research seeks to improve the prediction of T cell responses, paving the way for safer and more effective immunotherapies.

Dr. Aaron D. Gitler's lab at Stanford University focuses on understanding the biological mechanisms behind neurodegenerative diseases like ALS and Parkinson's disease. By using yeast and human genetics, the lab aims to uncover novel genetic risk factors and therapeutic strategies, including targeting specific proteins and RNA splicing events. Their work involves innovative technologies such as CRISPR and RNA sequencing to explore pathways that lead to these devastating conditions and to identify potential treatments.

Dr. Maria Barna's lab at Stanford University focuses on understanding how mutations in ribosomal proteins lead to specific blood and developmental disorders, such as Diamond-Blackfan Anemia (DBA). By examining the translation of genes within blood cells, they aim to uncover why certain tissues are affected by these mutations. The research could improve our knowledge of these diseases and lead to new treatments.

Dr. Lars M Steinmetz's lab at Stanford University focuses on understanding how genetic variations affect gene regulation and expression. By using advanced techniques like CRISPR and single-cell transcriptomics, the lab aims to uncover the complex networks that control how genes function and contribute to disease. This research could lead to better predictions about individual disease risks and more effective treatments based on genetic information.

Dr. Alice Y Ting's lab focuses on developing innovative enzymes that improve the mapping of proteins within living cells. Their research aims to create more effective methods for studying how proteins interact and organize within cells, which is essential for understanding various biological processes and diseases. By enhancing existing techniques and creating new ones, the lab seeks to advance our tools for exploring cellular dynamics and potential treatments for diseases.

Dr. Urban's lab at Stanford is focused on understanding the genetic variations that occur in individual cells within our bodies, a phenomenon known as somatic mosaicism. By developing and testing advanced techniques, the lab aims to accurately identify and characterize these genetic changes, which can have significant implications for understanding diseases and the biology of tissues. The work includes innovative methods to analyze the entire genome of single cells, which could lead to breakthroughs in personalized medicine.